Cargando…

External Validation of the Garvan Nomograms for Predicting Absolute Fracture Risk: The Tromsø Study

BACKGROUND: Absolute risk estimation is a preferred approach for assessing fracture risk and treatment decision making. This study aimed to evaluate and validate the predictive performance of the Garvan Fracture Risk Calculator in a Norwegian cohort. METHODS: The analysis included 1637 women and 135...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahmed, Luai A., Nguyen, Nguyen D., Bjørnerem, Åshild, Joakimsen, Ragnar M., Jørgensen, Lone, Størmer, Jan, Bliuc, Dana, Center, Jacqueline R., Eisman, John A., Nguyen, Tuan V., Emaus, Nina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4177811/
https://www.ncbi.nlm.nih.gov/pubmed/25255221
http://dx.doi.org/10.1371/journal.pone.0107695
_version_ 1782336842260021248
author Ahmed, Luai A.
Nguyen, Nguyen D.
Bjørnerem, Åshild
Joakimsen, Ragnar M.
Jørgensen, Lone
Størmer, Jan
Bliuc, Dana
Center, Jacqueline R.
Eisman, John A.
Nguyen, Tuan V.
Emaus, Nina
author_facet Ahmed, Luai A.
Nguyen, Nguyen D.
Bjørnerem, Åshild
Joakimsen, Ragnar M.
Jørgensen, Lone
Størmer, Jan
Bliuc, Dana
Center, Jacqueline R.
Eisman, John A.
Nguyen, Tuan V.
Emaus, Nina
author_sort Ahmed, Luai A.
collection PubMed
description BACKGROUND: Absolute risk estimation is a preferred approach for assessing fracture risk and treatment decision making. This study aimed to evaluate and validate the predictive performance of the Garvan Fracture Risk Calculator in a Norwegian cohort. METHODS: The analysis included 1637 women and 1355 aged 60+ years from the Tromsø study. All incident fragility fractures between 2001 and 2009 were registered. The predicted probabilities of non-vertebral osteoporotic and hip fractures were determined using models with and without BMD. The discrimination and calibration of the models were assessed. Reclassification analysis was used to compare the models performance. RESULTS: The incidence of osteoporotic and hip fracture was 31.5 and 8.6 per 1000 population in women, respectively; in men the corresponding incidence was 12.2 and 5.1. The predicted 5-year and 10-year probability of fractures was consistently higher in the fracture group than the non-fracture group for all models. The 10-year predicted probabilities of hip fracture in those with fracture was 2.8 (women) to 3.1 times (men) higher than those without fracture. There was a close agreement between predicted and observed risk in both sexes and up to the fifth quintile. Among those in the highest quintile of risk, the models over-estimated the risk of fracture. Models with BMD performed better than models with body weight in correct classification of risk in individuals with and without fracture. The overall net decrease in reclassification of the model with weight compared to the model with BMD was 10.6% (p = 0.008) in women and 17.2% (p = 0.001) in men for osteoporotic fractures, and 13.3% (p = 0.07) in women and 17.5% (p = 0.09) in men for hip fracture. CONCLUSIONS: The Garvan Fracture Risk Calculator is valid and clinically useful in identifying individuals at high risk of fracture. The models with BMD performed better than those with body weight in fracture risk prediction.
format Online
Article
Text
id pubmed-4177811
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-41778112014-10-02 External Validation of the Garvan Nomograms for Predicting Absolute Fracture Risk: The Tromsø Study Ahmed, Luai A. Nguyen, Nguyen D. Bjørnerem, Åshild Joakimsen, Ragnar M. Jørgensen, Lone Størmer, Jan Bliuc, Dana Center, Jacqueline R. Eisman, John A. Nguyen, Tuan V. Emaus, Nina PLoS One Research Article BACKGROUND: Absolute risk estimation is a preferred approach for assessing fracture risk and treatment decision making. This study aimed to evaluate and validate the predictive performance of the Garvan Fracture Risk Calculator in a Norwegian cohort. METHODS: The analysis included 1637 women and 1355 aged 60+ years from the Tromsø study. All incident fragility fractures between 2001 and 2009 were registered. The predicted probabilities of non-vertebral osteoporotic and hip fractures were determined using models with and without BMD. The discrimination and calibration of the models were assessed. Reclassification analysis was used to compare the models performance. RESULTS: The incidence of osteoporotic and hip fracture was 31.5 and 8.6 per 1000 population in women, respectively; in men the corresponding incidence was 12.2 and 5.1. The predicted 5-year and 10-year probability of fractures was consistently higher in the fracture group than the non-fracture group for all models. The 10-year predicted probabilities of hip fracture in those with fracture was 2.8 (women) to 3.1 times (men) higher than those without fracture. There was a close agreement between predicted and observed risk in both sexes and up to the fifth quintile. Among those in the highest quintile of risk, the models over-estimated the risk of fracture. Models with BMD performed better than models with body weight in correct classification of risk in individuals with and without fracture. The overall net decrease in reclassification of the model with weight compared to the model with BMD was 10.6% (p = 0.008) in women and 17.2% (p = 0.001) in men for osteoporotic fractures, and 13.3% (p = 0.07) in women and 17.5% (p = 0.09) in men for hip fracture. CONCLUSIONS: The Garvan Fracture Risk Calculator is valid and clinically useful in identifying individuals at high risk of fracture. The models with BMD performed better than those with body weight in fracture risk prediction. Public Library of Science 2014-09-25 /pmc/articles/PMC4177811/ /pubmed/25255221 http://dx.doi.org/10.1371/journal.pone.0107695 Text en © 2014 Ahmed et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Ahmed, Luai A.
Nguyen, Nguyen D.
Bjørnerem, Åshild
Joakimsen, Ragnar M.
Jørgensen, Lone
Størmer, Jan
Bliuc, Dana
Center, Jacqueline R.
Eisman, John A.
Nguyen, Tuan V.
Emaus, Nina
External Validation of the Garvan Nomograms for Predicting Absolute Fracture Risk: The Tromsø Study
title External Validation of the Garvan Nomograms for Predicting Absolute Fracture Risk: The Tromsø Study
title_full External Validation of the Garvan Nomograms for Predicting Absolute Fracture Risk: The Tromsø Study
title_fullStr External Validation of the Garvan Nomograms for Predicting Absolute Fracture Risk: The Tromsø Study
title_full_unstemmed External Validation of the Garvan Nomograms for Predicting Absolute Fracture Risk: The Tromsø Study
title_short External Validation of the Garvan Nomograms for Predicting Absolute Fracture Risk: The Tromsø Study
title_sort external validation of the garvan nomograms for predicting absolute fracture risk: the tromsø study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4177811/
https://www.ncbi.nlm.nih.gov/pubmed/25255221
http://dx.doi.org/10.1371/journal.pone.0107695
work_keys_str_mv AT ahmedluaia externalvalidationofthegarvannomogramsforpredictingabsolutefractureriskthetromsøstudy
AT nguyennguyend externalvalidationofthegarvannomogramsforpredictingabsolutefractureriskthetromsøstudy
AT bjørneremashild externalvalidationofthegarvannomogramsforpredictingabsolutefractureriskthetromsøstudy
AT joakimsenragnarm externalvalidationofthegarvannomogramsforpredictingabsolutefractureriskthetromsøstudy
AT jørgensenlone externalvalidationofthegarvannomogramsforpredictingabsolutefractureriskthetromsøstudy
AT størmerjan externalvalidationofthegarvannomogramsforpredictingabsolutefractureriskthetromsøstudy
AT bliucdana externalvalidationofthegarvannomogramsforpredictingabsolutefractureriskthetromsøstudy
AT centerjacqueliner externalvalidationofthegarvannomogramsforpredictingabsolutefractureriskthetromsøstudy
AT eismanjohna externalvalidationofthegarvannomogramsforpredictingabsolutefractureriskthetromsøstudy
AT nguyentuanv externalvalidationofthegarvannomogramsforpredictingabsolutefractureriskthetromsøstudy
AT emausnina externalvalidationofthegarvannomogramsforpredictingabsolutefractureriskthetromsøstudy